Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported outcome results of a randomised phase 3 trial.
Current urology reports.
Times cited: 71
Abiraterone in metastatic prostate cancer without previous chemotherapy.
New England Journal of Medicine.
Times cited: 1074